Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated...
-
Nashville, Tenn., Jan. 30, 2025 (GLOBE NEWSWIRE) -- LBMC, a top 40 public accounting firm and the largest Tennessee-based professional services and business consulting firm, announces the release of...
-
BOSTON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Risk Strategies, a leading national specialty insurance brokerage and risk management firm, today announced the acquisition of Comprehensive Benefits,...
-
IRVINE, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized...
-
CHARLOTTE, N.C., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Magnera (NYSE: MAGN) expects to release its 2025 first quarter results prior to trading on the New York Stock Exchange on Thursday, February 6,...
-
Terra Metals Inc. Advances Copper and Cobalt Operations in Zambia.
-
RALEIGH, N.C., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE:HIW) announces its Board of Directors has declared a cash dividend of $0.50 per share of common stock for the...
-
Chiffre d’affaires de 994,6 M€ sur l’ensemble de l’exercice 2024, en recul de -5,9 %, traduisant les orientations stratégiques du Groupe Priorité accrue donnée aux marges par rapport à la croissance...
-
€994.6 million in total revenue for 2024, down -5.9%, reflecting the Group’s strategic orientations Prioritizing margins over revenue growthManaged decrease in the most mature marketsFocus on the...
-
Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Endoscopic Retrograde Cholangiopancreatography Market Size, Share & Trends Analysis by Product, Procedure Type, End-use, and Region, 2025-2030"...